Canverixin

N/A

Report date: 2025/12/25 15:59:14
NMEFirst In Class

Base Information

Drug NameCanverixin
Drug Alias NameACT-1004-1239
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCXCR7 protein inhibitors
TargetsC-X-C chemokine receptor type 7
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPortugal
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIdorsia Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A